3M (NYSE: MMM) director adds 288 deferred stock equivalents

Rhea-AI Filing Summary

3M director James R. Fitterling reported a routine compensation deferral into stock equivalents. On January 23, 2026, an entity described as a corporation associated with him acquired 287.929 shares of 3M common stock equivalents at $160.63 per share, recorded as indirect ownership "By Corporation". According to the plan footnote, this non‑employee director elected to defer compensation into a common stock equivalents account under 3M’s Compensation Plan for Non‑Employee Directors and has no voting or investment powers over that account.

After this transaction, the corporation‑held indirect position is shown as 6,475.503 common stock equivalents. The filing also lists 11,412.005 shares of common stock held directly and 200 shares held indirectly By Spouse, which are reported holdings rather than new transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fitterling James R

(Last) (First) (Middle)

3M CENTER

(Street)

ST. PAUL MN 55144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
3M CO [ MMM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/23/2026		A		287.929	A	$160.63	6,475.503(1)(2)	I	By Corporation
Common Stock								11,412.005	D
Common Stock								200	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account.

2. Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors.

	Patricia L. Meagher, attorney-in-fact for James R. Fitterling	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did 3M (MMM) report for James R. Fitterling?

The filing shows an entity described as a corporation associated with director James R. Fitterling acquired 287.929 common stock equivalents of 3M on January 23, 2026, at $160.63 per share, as part of a compensation deferral.

Is the 3M director’s transaction a discretionary stock purchase?

No. The footnote states this non‑employee director elected to defer compensation into a common stock equivalents account under 3M’s Compensation Plan for Non‑Employee Directors, and that he has no voting or investment powers over that account.

How many 3M common stock equivalents does the corporation hold after the transaction?

Following the reported deferral, the indirect position labeled By Corporation shows 6,475.503 common stock equivalents beneficially owned.

What other 3M share holdings are reported for James R. Fitterling?

The Form 4 lists 11,412.005 shares of 3M common stock held directly and 200 shares held indirectly with the nature of ownership described as By Spouse. These entries represent reported holdings, not new transactions.

What do the footnotes say about voting and investment power over the deferred 3M shares?

The footnote explains that the director’s compensation is deferred into a common stock equivalents account and states he has no voting or investment powers with respect to that account. It also notes that the total includes deferred dividend reinvestment shares under the same plan.

Who is the reporting person in this 3M Form 4 filing and what is their role?

The reporting person is James R. Fitterling, identified in the filing as a director of 3M. The Form 4 is signed by Patricia L. Meagher as attorney‑in‑fact for him.